Calcineurin plays a critical role in pressure overload-induced cardiac hypertrophy

Masaki Shimoyama, Doubun Hayashi, Eiki Takimoto, Yunzeng Zou, Toru Oka, Hiroki Uozumi, Sumiyo Kudoh, Futoshi Shibasaki, Yoshio Yazaki, Ryozo Nagai, Issei Komuro

Research output: Contribution to journalArticlepeer-review


Background - Cardiac hypertrophy is a fundamental adaptive response to hemodynamic overload; how mechanical load induces cardiac hypertrophy, however, remains elusive. It was recently reported that activation of a calcium-dependent phosphatase, calcineurin, induces cardiac hypertrophy. In the present study, we examined whether calcineurin plays a critical role in pressure overload-induced cardiac hypertrophy. Methods and Results - Pressure overload produced by constriction of the abdominal aorta increased the activity of calcineurin in the rat heart and induced cardiac hypertrophy, including reprogramming of gene expression. Treatment of rats with a calcineurin inhibitor, FK506, inhibited the activation of calcineurin and prevented the pressure overload-induced cardiac hypertrophy and fibrosis without change of hemodynamic parameters. Load-induced expression of immediate-early-response genes and fetal genes was also suppressed by the FK506 treatment. Conclusions - The present results suggest that the calcineurin signaling pathway plays a pivotal role in load-induced cardiac hypertrophy and may pave the way for a novel pharmacological approach to prevent cardiac hypertrophy.

Original languageEnglish (US)
Pages (from-to)2449-2454
Number of pages6
Issue number24
StatePublished - Dec 14 1999
Externally publishedYes


  • Calcineurin
  • Genes
  • Hypertrophy
  • Pressure

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Calcineurin plays a critical role in pressure overload-induced cardiac hypertrophy'. Together they form a unique fingerprint.

Cite this